Good morning, and welcome to Johnson & Johnson's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the ...
Investor's Business Daily on MSN
IBD Rating Upgrades: Steven Madden Shows Improved Price Strength
The Relative Strength (RS) Rating for Steven Madden SHOO moved up into a higher percentile Tuesday, as it got a lift from 67 ...
Investor's Business Daily on MSN
Calumet Sees IBD RS Rating Rise To 77
Calumet CLMT saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 67 to 77.
The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback